Viewing Study NCT02434120


Ignite Creation Date: 2025-12-25 @ 4:08 AM
Ignite Modification Date: 2026-03-03 @ 3:53 PM
Study NCT ID: NCT02434120
Status: COMPLETED
Last Update Posted: 2024-04-16
First Post: 2015-04-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: MRI Perfusion Curves Typology and Orbital Tumors (PERFORM)
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Organization:

Study Overview

Official Title: Validation, for Orbital Tumors, of the MRI Perfusion Curves Typology Established for Salivary Tumors
Status: COMPLETED
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PERFORM
Brief Summary: Orbital masses develop at the expense of the orbital structures lacrimal glands, oculomotor muscles, optic nerve, meningeal spaces, peripheral nerves, bone wall, orbital fat, lymphoid structures or vascular structures. These masses can be tumors, benign or malignant, or pseudotumor, mainly represented by specific or non-specific orbital inflammation.

Pathology is of considerable importance for the diagnosis and the treatment of those masses. However, biopsy or surgical resection of the orbital masses is sometimes difficult and dangerous outside expert centers.

The identification of a non-invasive technique for distinguishing tumors from pseudotumors, thus avoid in some cases a biopsy, would be a major contribution for the patients.

For salivary glands, MRI allows to identify 4 different types of MRI characteristics, one (type C) being related to malignant tumors.

In this study, the investigators will try to see if extrapolation of those data to orbiltal tumors is feasible.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: